Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Anthera Pharmaceuticals Inc (NASDAQ:ANTH)

2.05
BATS BZX Real-Time Price
As of 12:11pm ET
 -0.01 / -0.49%
Today’s Change
1.20
Today|||52-Week Range
20.24
-60.52%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$28.5M

Company Description

Anthera Pharmaceuticals, Inc. is a biopharmaceutical company, which focuses on developing and commercializing products to treat serious and life-threatening diseases, including lupus, lupus with glomerulonephritis, IgA nephropathy, and exocrine pancreatic insufficiency due to cystic fibrosis. It develops phase 3 product candidates, which includes blisibimod and liprotamase. Anthera Pharmaceuticals was founded by Paul F. Truex on September 9, 2004 and is headquartered in Hayward, CA.

Contact Information

Anthera Pharmaceuticals, Inc.
25801 Industrial Boulevard
Hayward California 94545
P:(510) 856-5600
Investor Relations:
151085656005621

Employees

Shareholders

Mutual fund holders6.33%
Other institutional29.35%
Individual stakeholders0.41%

Top Executives

John Craig ThompsonPresident, Chief Executive Officer & Director
May LiuCAO, Senior VP-Finance & Administration
William R. ShanahanChief Medical Officer
Renee MartinSenior Vice President-Medical Science
Nikhil AgarwalHead-Investor Relations